W
GSK icon

WealthCollab’s GSK GSK Stock Holding History

WealthCollab’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.2K Buy
1,415
+170
+14% +$8.99K 0.03% 189
2026
Q1 		$68.7K Hold
1,245
– – 0.03% 171
2025
Q4 		$61.1K Buy
1,245
+213
+21% +$9.93K 0.03% 204
2025
Q3 		$44.5K Hold
1,032
– – 0.02% 210
2025
Q2 		$39.6K Sell
1,032
-331
-24% -$12.6K 0.02% 212
2025
Q1 		$52.8K Sell
1,363
-292
-18% -$10.7K 0.03% 156
2024
Q4 		$56K Sell
1,655
-945
-36% -$34K 0.04% 154
2024
Q3 		$106K Hold
2,600
– – 0.07% 99
2024
Q2 		$100K Hold
2,600
– – 0.07% 92
2024
Q1 		$111K Hold
2,600
– – 0.08% 82
2023
Q4 		$96.4K Buy
+2,600
New +$93.3K 0.08% 88

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

WealthCollab's GSK Position: Q2 2026 in Review

WealthCollab increased its GSK (GSK) stake by 14% in Q2 2026, buying an estimated $8.99K and bringing the position to 1,415 shares worth $74.2K. The position accounts for 0.03% of the portfolio, ranked #189.

WealthCollab first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $111K in Q1 2024. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • WealthCollab held 1,415 shares of GSK worth $74.2K as of Q2 2026.
  • WealthCollab bought 170 GSK shares in Q2 2026, an estimated $8.99K.
  • GSK made up 0.03% of WealthCollab's portfolio in Q2 2026, its #189 holding.
  • WealthCollab first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
  • WealthCollab's GSK position peaked at $111K in Q1 2024.
  • 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.